G1 Therapeutics Inc Corporate Analyst Meeting Transcript
Good morning, everyone. I think we're going to get started. First off, I wanted to thank everyone who's joined us here in New York as well as those of you on the webcast to G1 Therapeutics' First Investor Day.
Before we begin the program, I just would like to remind everyone that today's presentation will have forward-looking statements. You can see our full forward-looking statement here. You can also reference our filings with the SEC on our corporate website. So we encourage you to take a look at those.
Just a couple of housekeeping notes. There'll be Q&A sessions both in between -- in between both the trilaciclib and lerociclib/G1T48 sections of the agenda. For those of you in the room, if you're going to ask questions, there'll be someone with a microphone. Please ask your questions into the microphone and identify yourself, so the folks on the webcast can hear you. For those of you joining us by webcast, you can submit questions via the "Ask a Question" link that's at the top right of your screen.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |